other material
confidence high
sentiment neutral
materiality 0.65
Protara closes full underwriters' option, gross proceeds ~$86.3M from offering
Protara Therapeutics, Inc.
- Closed full exercise of underwriters' option for 1,956,521 shares at $5.75/share on Dec 15, 2025.
- Combined with Dec 8 firm shares (13,043,479), total gross proceeds expected ~$86.3M.
- Net proceeds to fund clinical development of TARA-002 and other programs.
- Offering made under effective S-3 registration statement (File No. 333-275290).